Published online 9 September 2002 doi:10.1084/jem.20020781
© Rockefeller University Press, 0022-1007/2002/9/859/ $5.00
The Journal of Experimental Medicine, Volume 196, Number 6, September 16, 2002 859-865
A Role for Immune Complexes in Enhanced Respiratory Syncytial Virus Disease
Fernando P. Polack1,2,3,
Michael N. Teng5,
Peter L.Collins5,
Gregory A. Prince6,
Marcus Exner7,
Heinz Regele8,
Dario D. Lirman1,3,
Richard Rabold4,
Scott J. Hoffman1,3,
Christopher L. Karp10,
Steven R. Kleeberger9,
Marsha Wills-Karp11 and
Ruth A. Karron1,2
1 Department of Pediatrics, School of Medicine
2 Department of International Health, Bloomberg School of Public Health at Johns Hopkins University, Baltimore, MD 21205
3 Department of Molecular Microbiology and Immunology, Bloomberg School of Public Health at Johns Hopkins University, Baltimore, MD 21205
4 Department of Environmental Health, Bloomberg School of Public Health at Johns Hopkins University, Baltimore, MD 21205
5 National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892
6 Virion Systems Inc., Rockville, MD 20850
7 Department of Laboratory Medicine, University of Vienna, Vienna A-1090, Austria
8 Department of Clinical Pathology, University of Vienna, Vienna A-1090, Austria
9 National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle, NC 27709
10 Division of Molecular Immunology, Children's Hospital Research Foundation, Cincinnati, OH 45229
11 Division of Immunobiology, Children's Hospital Research Foundation, Cincinnati, OH 45229
Address correspondence to Fernando P. Polack, Johns Hopkins Bloomberg School of Public Health, 615 N. Wolfe St., W5102, Baltimore, MD 21205. Phone: 410-955-1622; Fax: 410-955- 2791; E-mail: fpolack{at}jhsph.edu
Respiratory syncytial virus (RSV) is the leading cause of bronchiolitis and viral pneumonia in infants and young children. Administration of a formalin inactivated vaccine against RSV to children in the 1960s resulted in increased morbidity and mortality in vaccine recipients who subsequently contracted RSV. This incident precluded development of subunit RSV vaccines for infants for over 30 years, because the mechanism of illness was never clarified. An RSV vaccine for infants is still not available.
Here, we demonstrate that enhanced RSV disease is mediated by immune complexes and abrogated in complement component C3 and B celldeficient mice but not in controls. Further, we show correlation with the enhanced disease observed in children by providing evidence of complement activation in postmortem lung sections from children with enhanced RSV disease.
Key Words: respiratory syncytial virus enhanced disease immune complexes airway hyperresponsiveness compliment

CiteULike
Complore
Connotea
Del.icio.us
Digg
Facebook
Reddit
Technorati
Twitter What's this?
This article has been cited by other articles:
-
Kovacs-Nolan, J., Mapletoft, J. W., Lawman, Z., Babiuk, L. A., van Drunen Littel-van den Hurk, S.
(2009). Formulation of bovine respiratory syncytial virus fusion protein with CpG oligodeoxynucleotide, cationic host defence peptide and polyphosphazene enhances humoral and cellular responses and induces a protective type 1 immune response in mice. J. Gen. Virol.
90: 1892-1905
[Abstract]
[Full Text]
-
Percopo, C. M., Qiu, Z., Phipps, S., Foster, P. S., Domachowske, J. B., Rosenberg, H. F.
(2009). Pulmonary Eosinophils and Their Role in Immunopathologic Responses to Formalin-Inactivated Pneumonia Virus of Mice. J. Immunol.
183: 604-612
[Abstract]
[Full Text]
-
Ruckwardt, T. J., Bonaparte, K. L., Nason, M. C., Graham, B. S.
(2009). Regulatory T Cells Promote Early Influx of CD8+ T Cells in the Lungs of Respiratory Syncytial Virus-Infected Mice and Diminish Immunodominance Disparities. J. Virol.
83: 3019-3028
[Abstract]
[Full Text]
-
Collins, P. L., Graham, B. S.
(2008). Viral and Host Factors in Human Respiratory Syncytial Virus Pathogenesis. J. Virol.
82: 2040-2055
[Full Text]
-
Wills-Karp, M.
(2007). Complement Activation Pathways: A Bridge between Innate and Adaptive Immune Responses in Asthma. Proc Am Thorac Soc
4: 247-251
[Abstract]
[Full Text]
-
Morrison, T. E., Fraser, R. J., Smith, P. N., Mahalingam, S., Heise, M. T.
(2007). Complement Contributes to Inflammatory Tissue Destruction in a Mouse Model of Ross River Virus-Induced Disease. J. Virol.
81: 5132-5143
[Abstract]
[Full Text]
-
Wang, J. P., Asher, D. R., Chan, M., Kurt-Jones, E. A., Finberg, R. W.
(2007). Cutting Edge: Antibody-Mediated TLR7-Dependent Recognition of Viral RNA. J. Immunol.
178: 3363-3367
[Abstract]
[Full Text]
-
Martinez, I., Lombardia, L., Garcia-Barreno, B., Dominguez, O., Melero, J. A.
(2007). Distinct gene subsets are induced at different time points after human respiratory syncytial virus infection of A549 cells. J. Gen. Virol.
88: 570-581
[Abstract]
[Full Text]
-
Melendi, G. A., Hoffman, S. J., Karron, R. A., Irusta, P. M., Laham, F. R., Humbles, A., Schofield, B., Pan, C.-H., Rabold, R., Thumar, B., Thumar, A., Gerard, N. P., Mitzner, W., Barnum, S. R., Gerard, C., Kleeberger, S. R., Polack, F. P.
(2007). C5 Modulates Airway Hyperreactivity and Pulmonary Eosinophilia during Enhanced Respiratory Syncytial Virus Disease by Decreasing C3a Receptor Expression. J. Virol.
81: 991-999
[Abstract]
[Full Text]
-
Openshaw, P. J. M.
(2005). Antiviral Immune Responses and Lung Inflammation after Respiratory Syncytial Virus Infection. Proc Am Thorac Soc
2: 121-125
[Abstract]
[Full Text]
-
Braciale, T. J.
(2005). Respiratory Syncytial Virus and T Cells: Interplay between the Virus and the Host Adaptive Immune System. Proc Am Thorac Soc
2: 141-146
[Abstract]
[Full Text]
-
Openshaw, P. J. M., Tregoning, J. S.
(2005). Immune Responses and Disease Enhancement during Respiratory Syncytial Virus Infection. Clin. Microbiol. Rev.
18: 541-555
[Abstract]
[Full Text]
-
Polack, F. P., Irusta, P. M., Hoffman, S. J., Schiatti, M. P., Melendi, G. A., Delgado, M. F., Laham, F. R., Thumar, B., Hendry, R. M., Melero, J. A., Karron, R. A., Collins, P. L., Kleeberger, S. R.
(2005). The cysteine-rich region of respiratory syncytial virus attachment protein inhibits innate immunity elicited by the virus and endotoxin. Proc. Natl. Acad. Sci. USA
102: 8996-9001
[Abstract]
[Full Text]
-
Huang, Y., Anderson, R.
(2005). Modulation of Protective Immunity, Eosinophilia, and Cytokine Responses by Selective Mutagenesis of a Recombinant G Protein Vaccine against Respiratory Syncytial Virus. J. Virol.
79: 4527-4532
[Abstract]
[Full Text]
-
Oumouna, M., Mapletoft, J. W., Karvonen, B. C., Babiuk, L. A., van Drunen Littel-van den Hurk, S.
(2005). Formulation with CpG Oligodeoxynucleotides Prevents Induction of Pulmonary Immunopathology following Priming with Formalin-Inactivated or Commercial Killed Bovine Respiratory Syncytial Virus Vaccine. J. Virol.
79: 2024-2032
[Abstract]
[Full Text]
-
Johnson, T. R., Teng, M. N., Collins, P. L., Graham, B. S.
(2004). Respiratory Syncytial Virus (RSV) G Glycoprotein Is Not Necessary for Vaccine-Enhanced Disease Induced by Immunization with Formalin-Inactivated RSV. J. Virol.
78: 6024-6032
[Abstract]
[Full Text]
-
Antonis, A. F. G., Schrijver, R. S., Daus, F., Steverink, P. J. G. M., Stockhofe, N., Hensen, E. J., Langedijk, J. P. M., van der Most, R. G.
(2003). Vaccine-Induced Immunopathology during Bovine Respiratory Syncytial Virus Infection: Exploring the Parameters of Pathogenesis. J. Virol.
77: 12067-12073
[Abstract]
[Full Text]
-
Johnson, T. R., Parker, R. A., Johnson, J. E., Graham, B. S.
(2003). IL-13 Is Sufficient for Respiratory Syncytial Virus G Glycoprotein-Induced Eosinophilia After Respiratory Syncytial Virus Challenge. J. Immunol.
170: 2037-2045
[Abstract]
[Full Text]
-
Culley, F. J., Pollott, J., Openshaw, P. J.M.
(2002). Age at First Viral Infection Determines the Pattern of T Cell-mediated Disease during Reinfection in Adulthood. JEM
196: 1381-1386
[Abstract]
[Full Text]